CytomX Therapeutics Inc. (NASDAQ: CTMX)
$1.50
+0.0900 ( +6.38% ) 856.0K
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Market Data
Open
$1.50
Previous close
$1.41
Volume
856.0K
Market cap
$117.66M
Day range
$1.42 - $1.52
52 week range
$1.04 - $5.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 61 | May 08, 2024 |
8-k | 8K-related | 15 | May 08, 2024 |
8-k | 8K-related | 12 | May 08, 2024 |
def | Proxies and info statements | 6 | Apr 04, 2024 |
4 | Insider transactions | 1 | Mar 28, 2024 |
pre | Proxies and info statements | 6 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 22, 2024 |
8-k | 8K-related | 14 | Mar 22, 2024 |
3 | Insider transactions | 2 | Mar 22, 2024 |
4 | Insider transactions | 1 | Mar 21, 2024 |